Medicare Info Collection: Comment Before March Deadline Hits
Published Date: 2/13/2026
Notice
Summary
The Centers for Medicare & Medicaid Services (CMS) wants your thoughts on their plan to keep collecting important info from the public. If you or your group deal with Medicare or Medicaid, this affects you! You’ve got until March 16, 2026, to share your ideas on how to make this process easier and better, with no new costs announced.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Full-Subsidy Auto-Deeming for Dual-Eligibles
CMS automatically deems certain individuals eligible for the full Part D subsidy each month based on State Medicaid agency and SSA data, and auto-assigns those beneficiaries to benchmark Part D plans (Form CMS-10344). This collection covers 51 respondents and reports 612 total annual hours, and it supports premium and cost-sharing subsidy administration under the statute cited in the notice.
Medicare Advantage & Part D Notice Rules
Medicare Advantage organizations and Part D sponsors must use CMS-standard disclosure documents (Form CMS-10260). Enrollees must receive the Annual Notice of Change (ANOC) by September 30, and the Evidence of Coverage (EOC) must be provided 15 days before the start of the Annual Enrollment Period. CMS reports 712 respondents, 45,996 responses, and 12,316 total annual hours for this collection.
National OAS CAHPS Patient Survey Rollout
CMS is implementing the national Outpatient and Ambulatory Surgery CAHPS (OAS CAHPS) survey to collect patient assessments for many patient groups, including patients covered by Medicare and Medicaid. CMS-approved vendors may administer the survey by mail-only, telephone-only, or mixed modes (including web), and CMS reports 2,045,727 respondents and 500,805 total annual hours for this collection.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10292 — Medicaid Program; Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments
This proposed rule changes how states can pay Medicaid managed care plans and certain doctors to make sure payments are fair, efficient, and encourage enough providers to offer quality care. It affects states, Medicaid managed care organizations, and targeted Medicaid practitioners, aiming to keep payments balanced and services available. Comments on these changes are open until July 21, 2026, so stakeholders have time to weigh in before it’s finalized.
2026-10050 — Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program
Starting in 2027, health insurance plans on federal and state marketplaces will see new rules to make coverage fairer and easier to use. These changes affect insurance companies, agents, and people buying plans, including new fees, penalties, and better protections for those with hardships. Expect updates on plan quality, dental coverage limits, and longer-term catastrophic plans, all aiming to keep your health coverage solid and affordable.
2026-07205 — Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges
This new rule will help Medicare, Medicaid, CHIP, and health plan companies share patient info more easily and speed up drug approval requests. It affects Medicare Advantage, Medicaid, CHIP, and health plans on federal exchanges, aiming to make care smoother and faster. These changes will start soon and could save time and money by cutting red tape.
2026-04797 — Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction
This document fixes some typos and technical mistakes in the Medicare and Medicaid payment rules for 2026. It affects doctors, healthcare providers, and anyone using Medicare Part B by clarifying payment policies and program requirements starting January 1, 2026. These corrections help make sure payments and coverage rules are clear and accurate, so everyone gets paid right and on time.
2026-04467 — Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction
This correction fixes some missing labels in important tables from the 2027 health insurance rules under the Affordable Care Act. It mainly affects insurance companies and people using marketplace plans by clarifying how risk and payments are calculated. These fixes take effect right away on March 6, 2026, ensuring everyone has clear info before the 2027 plan year starts.
2025-23081 — Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2026 and Updates to the IRF Quality Reporting Program; Correction
This correction fixes some math and typo mistakes in the Medicare payment rules for inpatient rehab facilities starting October 1, 2025. It mainly affects rehab centers by updating their payment rates and quality reporting details to be fair and accurate. These changes ensure providers get the right money and info for the 2026 fiscal year.
Previous / Next Documents
Previous: 2026-02966 — Agency Information Collection Activities: Submission for OMB Review; Comment Request
The Centers for Medicare & Medicaid Services (CMS) wants your thoughts on their plan to collect info from the public. This helps make sure the paperwork isn’t too much and is useful. If you have ideas or concerns, send them by April 14, 2026—this keeps things fair and clear for everyone involved.
Next: 2026-02968 — Determination of Regulatory Review Period for Purposes of Patent Extension; ALYFTREK
The FDA has set the official review period for ALYFTREK, a new drug, so its patent holder can apply for extra patent time. This helps the company protect their invention longer, potentially delaying generic competition and affecting drug prices. If anyone thinks the dates are wrong or wants to challenge the company’s review speed, they have until April or August 2026 to speak up.